Tricyclic antipsychotic compounds
    5.
    发明授权
    Tricyclic antipsychotic compounds 失效
    三环抗精神病药

    公开(公告)号:US5681840A

    公开(公告)日:1997-10-28

    申请号:US584634

    申请日:1996-01-11

    摘要: Compounds of formula I or I', ##STR1## wherein X and Y are independently selected from hydrogen, halo, and (1-6C)alkoxy; R.sup.1 is selected from (A) (1-6C)alkyl; (B) phenyl and naphthyl or substituted versions thereof; (C) phenyl(1-3C)alkyl and naphthyl(1-3C)alkyl; (D) five- and six-membered heteroaryl rings; (E) heteroaryl(1-3C)alkyl and pharmaceutically acceptable salts thereof, useful in the treatment of neuropsychiatric disorders such as psychoses; pharmaceutical compositions comprising a compound of formula I or I' and a pharmaceutically acceptable diluent or carrier; and methods of treating neuropsychiatric disorders comprising administering to a mammal (including man) in need of such treatment an effective amount of a compound of formula I or I', or a pharmaceutically acceptable salt thereof are claimed. The invention also relates to novel processes for producing enantiomeric methanoanthracenyl sulfoxides.

    摘要翻译: 式I或I'化合物,其中X和Y独立地选自氢,卤素和(1-6C)烷氧基; R1选自(A)(1-6C)烷基; (B)苯基和萘基或其取代形式; (C)苯基(1-3C)烷基和萘基(1-3C)烷基; (D)五元和六元杂芳环; (E)杂芳基(1-3C)烷基及其药学上可接受的盐,可用于治疗神经精神障碍如精神病; 包含式I或I'化合物的药物组合物和药学上可接受的稀释剂或载体; 以及治疗神经精神障碍的方法,包括向需要这种治疗的哺乳动物(包括人)施用有效量的式I或I'化合物或其药学上可接受的盐。 本发明还涉及产生对映异构体的甲烷基蒽基亚砜的新方法。